Downtrend on the daily chart: below its 50- and 200-day averages · 50-day below the 200-day · SuperTrend down since Aug 16 · below the Ichimoku cloud · RSI 52 · MACD above its signal · 6% above its 52-week low
None of the 29 investors followed here reported a position in 1666.HK in their latest filing.
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
No member of Congress has disclosed a 1666.HK trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
No insider transactions reported for 1666.HK.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -2.3 | 1.9 | -9.8 | -2.8 | -8.3 | -9.1 | 10.0 | -16.1 | 5.6 | 0.3 | −28.9% | ||
| 2025 | -5.6 | -4.5 | 1.7 | -0.4 | 7.4 | -3.1 | 6.7 | -5.7 | -4.0 | -2.5 | 2.2 | -7.2 | −15.2% |
| 2024 | -13.6 | -9.2 | -5.3 | 11.1 | -1.5 | -5.4 | -0.8 | -1.2 | 17.0 | -11.6 | -1.2 | 2.8 | −20.8% |
| 2023 | 4.2 | -4.4 | 22.6 | 22.8 | -18.1 | 12.1 | -10.0 | -10.1 | -1.0 | -4.3 | 10.2 | -0.3 | +15.9% |
| 2022 | -13.2 | -7.2 | -0.9 | -9.7 | -2.6 | 12.1 | -16.2 | 0.7 | -17.6 | -12.0 | 28.0 | 9.5 | −32.6% |
| 2021 | 0.4 | 7.8 | 0.6 | 16.0 | 26.6 | -8.6 | -19.6 | 1.2 | 0.7 | -5.7 | 6.7 | 42.5 | +71.7% |
| 2020 | -6.0 | 0.0 | -14.2 | 0.0 | -6.1 | 1.6 | -3.1 | 5.1 | -18.2 | -7.5 | 20.9 | -11.1 | −36.3% |
| 2019 | 2.7 | -2.5 | 2.5 | 3.2 | -7.7 | -7.3 | 1.0 | -9.5 | -16.2 | 9.5 | -13.6 | 13.5 | −25.3% |
| 2018 | 11.2 | 5.4 | -1.2 | -3.1 | 7.6 | -8.7 | -7.2 | -1.6 | 0.7 | -2.1 | -0.2 | -8.4 | −9.2% |
| 2017 | -3.5 | 2.6 | -2.9 | -5.2 | -6.4 | -1.6 | -6.1 | -2.8 | -9.2 | 9.7 | -0.2 | 3.3 | −21.4% |
| 2016 | -6.4 | 0.5 | 4.2 | -2.2 | 3.8 | 1.4 | -4.5 | 12.3 | 9.2 | -5.6 | 4.4 | -2.7 | +13.1% |
| 2015 | -3.2 | -1.4 | 19.2 | 18.9 | 3.5 | -6.6 | -8.5 | -16.5 | 5.4 | 15.0 | -1.8 | 6.7 | +26.9% |
| 2014 | 7.7 | 1.9 | -8.3 | -10.2 | -1.6 | 2.9 | -2.5 | -1.4 | -1.5 | -2.8 | 2.5 | -6.2 | −19.0% |
| 2013 | 16.4 | 9.4 | 21.3 | -2.5 | -5.0 | -3.3 | 13.9 | -4.6 | -2.9 | -6.0 | 0.9 | 4.4 | +44.6% |
| 2012 | 0.7 | 6.8 | 12.7 | 9.5 | 0.2 | 10.6 | 15.2 | -1.0 | 1.7 | -3.9 | 19.8 | 2.5 | +101.4% |
| 2011 | -8.7 | 4.7 | 16.7 | 5.3 | -18.5 | 1.9 | 1.8 | 9.8 | -14.5 | 9.6 | 6.3 | 0.0 | +8.5% |
| 2010 | -4.9 | 5.3 | -1.1 | 23.6 | -11.9 | 0.9 | 1.2 | 1.8 | 40.2 | 4.6 | 1.7 | 0.6 | +68.1% |
| 2009 | -0.8 | 10.7 | 31.4 | 0.0 | 32.0 | -8.3 | 2.5 | -6.0 | 9.6 | 18.8 | 7.8 | -6.0 | +121.9% |
| 2008 | -13.1 | 0.8 | -17.8 | 7.1 | 2.7 | -8.0 | -7.6 | -15.1 | -20.7 | -26.9 | 5.4 | 24.3 | −56.6% |
| 2007 | 17.7 | -2.1 | -3.4 | 11.0 | 30.2 | 5.1 | -5.2 | -9.0 | -2.8 | -5.7 | -15.8 | 3.9 | +17.1% |
Tong Ren Tang Technologies Co. Ltd., together with its subsidiaries, produces and distributes Chinese medicine products in Mainland China and Hong Kong. It operates through three segments: The Company; Tong Ren Tang Chinese Medicine; and Others. The company develops, cultivates, processes, and purchases Chinese medicinal raw materials; retails and wholesales Chinese medicine products and healthcare products. It also offers ointments, healthcare products, tea drinks, food, foot care products, biological products, western medicine, and cosmetics. In addition, it provides medical research and development; advertisement; and Chinese medical consultations and treatments. Further, the company produces and processes biochemical products; extracts and processes plants; and offers medical services. Tong Ren Tang Technologies Co. Ltd. was founded in 1669 and is based in Beijing, the People's Republic of China.
No recent headlines.